pCMV-T7-AsCas12a-P2A-EGFP (RTW2861) Citations (2)
Originally described in: Scalable characterization of the PAM requirements of CRISPR-Cas enzymes using HT-PAMDA.Walton RT, Hsu JY, Joung JK, Kleinstiver BP Nat Protoc. 2021 Feb 5. pii: 10.1038/s41596-020-00465-2. doi: 10.1038/s41596-020-00465-2. PubMed Journal
Articles Citing pCMV-T7-AsCas12a-P2A-EGFP (RTW2861)
| Articles |
|---|
| Harnessing noncanonical crRNAs to improve functionality of Cas12a orthologs. Nguyen LT, Macaluso NC, Rakestraw NR, Carman DR, Pizzano BLM, Hautamaki RC, Rananaware SR, Roberts IE, Jain PK. Cell Rep. 2024 Feb 27;43(2):113777. doi: 10.1016/j.celrep.2024.113777. Epub 2024 Feb 14. PubMed |
| DNA-guided CRISPR-Cas12 for cellular RNA targeting. Orosco C, Huang B, Rananaware SR, Bodin AP, Browning I, Fang A, Baugh MP, Lange IH, Elhabashy YB, Balaraju M, Lewis JG, Shah NH, Hanna MP, Flannery SJ, Meister KS, Karalkar V, Jain PK. Nat Biotechnol. 2026 May 15. doi: 10.1038/s41587-026-03129-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.